Assessment of Burden of COPD (ABC) tool: Perception versus evidence

European Respiratory Journal

Volumn 49, Issue 3, 2017, Pages

  Houben Wilke, Sarah ^a   Franssen, Frits M E ^b   Kok, Ineke ^c   Otten, Henk J ^d   Wempe, Johan P ^e   Vercoulen, Jan H ^f  

^a Dutch Lung Centers   (Netherlands)

^b Center of Expertise for Chronic Organ Failure   (Netherlands)

^c Merem Treatment Centers   (Netherlands)

^d Revant Pulmonary Rehabilitation Center 'schoondonck'   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASSESSMENT OF BURDEN OF COPD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; DAILY LIFE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EDITORIAL; HEALTH CARE QUALITY; HOSPITALIZATION; HUMAN; PATIENT-REPORTED OUTCOME; PERCEPTION; PERSONALIZED MEDICINE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE ASSESSMENT; SMOKING; COST OF ILLNESS; HEALTH STATUS; MENTAL HEALTH; NETHERLANDS; PATHOPHYSIOLOGY; PSYCHOLOGY; QUESTIONNAIRE;

COST OF ILLNESS; HEALTH STATUS; HUMANS; MENTAL HEALTH; NETHERLANDS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES;

EID: 85034757863     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.02382-2016     Document Type: Editorial

References (23)

1. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187: 728–735.
2. Divo MJ, Casanova C, Marin JM, et al. COPD comorbidities network. Eur Respir J 2015; 46: 640–650.
3. Spruit MA, Augustin IM, Vanfleteren LE, et al. Differential response to pulmonary rehabilitation in COPD: multidimensional profiling. Eur Respir J 2015; 46: 1625–1635.
4. Wouters EF, Augustin IM. COPD health-care delivery: a holistic and dynamic approach is needed. Lancet Respir Med 2016; 4: e30–e31.
5. Agusti A, MacNee W. The COPD control panel: towards personalised medicine in COPD. Thorax 2013; 68: 687–690.
6. Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009; 374: 704–711.
7. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005–1012.
8. Williams JE, Green RH, Warrington V, et al. Development of the i-BODE: validation of the incremental shuttle walking test within the BODE index. Respir Med 2012; 106: 390–396.
9. Jones RC, Donaldson GC, Chavannes NH, et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. Am J Respir Crit Care Med 2009; 180: 1189–1195.
10. Esteban C, Quintana JM, Aburto M, et al. A simple score for assessing stable chronic obstructive pulmonary disease. QJM 2006; 99: 751–759.
11. Dijk WD, Bemt L, Haak-Rongen S, et al. Multidimensional prognostic indices for use in COPD patient care. A systematic review. Respir Res 2011; 12: 151.
12. US Food and Drug Administration. Guidance for Industry Patient-reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. US Department of Health and Human Services, Food and Drug Administration; Center for Drug Evaluation and Research (CDER); Center for Biologics Evaluation and Research (CBER); Center for Devices and Radiological Health (CDRH), 2009. Available from: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf
13. Curtis JR, Patrick DL. The assessment of health status among patients with COPD. Eur Respir J 2003; 41: 36s–45s.
14. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001; 56: 880–887.
15. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347–365.
16. Wilke S, Jones PW, Müllerova H, et al. One-year change in health status and subsequent outcomes in COPD. Thorax 2015; 70: 420–425.
17. van der Molen T, Willemse BW, Schokker S, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Out 2003; 1: 13.
18. Slok AH, in ‘t Veen JC, Chavannes NH, et al. Development of the Assessment of Burden of COPD tool: an integrated tool to measure the burden of COPD. NPJ Prim Care Respir Med 2014; 24: 14021.
19. Slok AH, Kotz D, van Breukelen G, et al. Effectiveness of the Assessment of Burden of COPD (ABC) tool on health-related quality of life in patients with COPD: a cluster randomised controlled trial in primary and hospital care. BMJ Open 2016; 6: e011519.
20. Slok AH, In ‘t Veen JC, Chavannes NH, et al. Effectiveness of the Assessment of Burden of Chronic Obstructive Pulmonary Disease (ABC) tool: study protocol of a cluster randomised trial in primary and secondary care. BMC Pulm Med 2014; 14: 131.
21. Kaljouw M, van Vliet K. Naar nieuwe zorg en zorgberoepen: de contouren. Diemen, Zorginstituut Nederland, 2015.
22. Vanfleteren LE, Spruit MA, Wouters EF, et al. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir Med 2016; 4: 911–924.
23. Weldam SW, Schuurmans MJ, Liu R, et al. Evaluation of Quality of Life instruments for use in COPD care and research: A systematic review. Int J Nurs Stud 2013; 50: 688–707.